Literature DB >> 24646282

From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?

Vanessa Flaten, Cyril Laurent, Joana E Coelho1, Ursula Sandau2, Vânia L Batalha1, Sylvie Burnouf, Malika Hamdane, Sandrine Humez, Detlev Boison2, Luísa V Lopes1, Luc Buée, David Blum.   

Abstract

AD (Alzheimer's disease) is the most prevalent form of dementia in the aged population. Definitive diagnosis of AD is based on the presence of senile plaques and neurofibrillary tangles that are identified in post-mortem brain specimens. A third pathological component is inflammation. AD results from multiple genetic and environmental risk factors. Among other factors, epidemiological studies report beneficial effects of caffeine, a non-selective antagonist of adenosine receptors. In the present review, we discuss the impact of caffeine and the adenosinergic system in AD pathology as well as consequences in terms of pathology and therapeutics.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24646282      PMCID： PMC4440674          DOI： 10.1042/BST20130229

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN： 0300-5127            Impact factor:   5.407


  73 in total

1.  Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission.

Authors:  Ann Van der Jeugd; Tariq Ahmed; Sylvie Burnouf; Karim Belarbi; Malika Hamdame; Marie-Eve Grosjean; Sandrine Humez; Detlef Balschun; David Blum; Luc Buée; Rudi D'Hooge
Journal:  Neurobiol Learn Mem       Date:  2010-12-16       Impact factor: 2.877

2.  Nuclear tau, a key player in neuronal DNA protection.

Authors:  Audrey Sultan; Fabrice Nesslany; Marie Violet; Séverine Bégard; Anne Loyens; Smail Talahari; Zeyni Mansuroglu; Daniel Marzin; Nicolas Sergeant; Sandrine Humez; Morvane Colin; Eliette Bonnefoy; Luc Buée; Marie-Christine Galas
Journal:  J Biol Chem       Date:  2010-12-03       Impact factor: 5.157

Review 3.  Current evidence for neuroprotective effects of nicotine and caffeine against Parkinson's disease.

Authors:  G W Ross; H Petrovitch
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

4.  Genetic mechanisms of coffee extract protection in a Caenorhabditis elegans model of β-amyloid peptide toxicity.

Authors:  Vishantie Dostal; Christine M Roberts; Christopher D Link
Journal:  Genetics       Date:  2010-08-30       Impact factor: 4.562

5.  Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2a-receptors.

Authors:  B L Fiebich; K Biber; K Lieb; D van Calker; M Berger; J Bauer; P J Gebicke-Haerter
Journal:  Glia       Date:  1996-10       Impact factor: 7.452

6.  Local glutamate level dictates adenosine A2A receptor regulation of neuroinflammation and traumatic brain injury.

Authors:  Shuang-Shuang Dai; Yuan-Guo Zhou; Wei Li; Jian-Hong An; Ping Li; Nan Yang; Xing-Yun Chen; Ren-Ping Xiong; Ping Liu; Yan Zhao; Hai-Ying Shen; Pei-Fang Zhu; Jiang-Fan Chen
Journal:  J Neurosci       Date:  2010-04-21       Impact factor: 6.167

7.  Enhancement of LTP in aged rats is dependent on endogenous BDNF.

Authors:  Maria J Diógenes; Ana R Costenla; Luísa V Lopes; André Jerónimo-Santos; Vasco C Sousa; Bruno M Fontinha; Joaquim A Ribeiro; Ana M Sebastião
Journal:  Neuropsychopharmacology       Date:  2011-04-27       Impact factor: 7.853

8.  Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology.

Authors:  Manuela Polydoro; Christopher M Acker; Karen Duff; Pablo E Castillo; Peter Davies
Journal:  J Neurosci       Date:  2009-08-26       Impact factor: 6.167

9.  Adenosine A2A receptor antagonists exert motor and neuroprotective effects by distinct cellular mechanisms.

Authors:  Liqun Yu; Hai-Ying Shen; Joana E Coelho; Inês M Araújo; Qing-Yuan Huang; Yuan-Ji Day; Nelson Rebola; Paula M Canas; Erica Kirsten Rapp; Jarrod Ferrara; Darcie Taylor; Christa E Müller; Joel Linden; Rodrigo A Cunha; Jiang-Fan Chen
Journal:  Ann Neurol       Date:  2008-03       Impact factor: 10.422

10.  Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging.

Authors:  Joan Lindsay; Danielle Laurin; René Verreault; Réjean Hébert; Barbara Helliwell; Gerry B Hill; Ian McDowell
Journal:  Am J Epidemiol       Date:  2002-09-01       Impact factor: 4.897
View more
  20 in total

1.  Caffeine exposure ameliorates acute ischemic cell death in avian developing retina.

Authors:  D Pereira-Figueiredo; R Brito; D S M Araújo; A A Nascimento; E S B Lyra; A M S S Cheibub; A D Pereira Netto; A L M Ventura; R Paes-de-Carvalho; K C Calaza
Journal:  Purinergic Signal       Date:  2020-02-20       Impact factor: 3.765

2.  A2A adenosine receptor deletion is protective in a mouse model of Tauopathy.

Authors:  C Laurent; S Burnouf; B Ferry; V L Batalha; J E Coelho; Y Baqi; E Malik; E Mariciniak; S Parrot; A Van der Jeugd; E Faivre; V Flaten; C Ledent; R D'Hooge; N Sergeant; M Hamdane; S Humez; C E Müller; L V Lopes; L Buée; D Blum
Journal:  Mol Psychiatry       Date:  2014-12-02       Impact factor: 15.992

3.  Effect of Caffeine Chronically Consumed During Pregnancy on Adenosine A1 and A2A Receptors Signaling in Both Maternal and Fetal Heart from Wistar Rats.

Authors:  Inmaculada Iglesias; Jose Luis Albasanz; Mairena Martín
Journal:  J Caffeine Res       Date:  2014-12-01

4.  Lifestyle Factors and Dementia in the Oldest-old: The 90+ Study.

Authors:  Annlia Paganini-Hill; Claudia H Kawas; Maria M Corrada
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Jan-Mar       Impact factor: 2.703

5.  Divergent Effects of the Nonselective Adenosine Receptor Antagonist Caffeine in Pre-Manifest and Motor-Manifest Huntington's Disease.

Authors:  Jannis Achenbach; Andreas Matusch; David Elmenhorst; Andreas Bauer; Carsten Saft
Journal:  Biomedicines       Date:  2022-05-27

6.  Caffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation.

Authors:  Mahmoud L Soliman; Jonathan D Geiger; Xuesong Chen
Journal:  J Neuroimmune Pharmacol       Date:  2016-09-15       Impact factor: 4.147

7.  Caffeine, Through Adenosine A3 Receptor-Mediated Actions, Suppresses Amyloid-β Protein Precursor Internalization and Amyloid-β Generation.

Authors:  Shanshan Li; Nicholas H Geiger; Mahmoud L Soliman; Liang Hui; Jonathan D Geiger; Xuesong Chen
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

8.  Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cells.

Authors:  Li-Fang Zhang; Zhi-Wei Zhou; Zhen-Hai Wang; Yan-Hui Du; Zhi-Xu He; Chuanhai Cao; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2014-12-24       Impact factor: 4.162

9.  Relationships Between Caffeine Intake and Risk for Probable Dementia or Global Cognitive Impairment: The Women's Health Initiative Memory Study.

Authors:  Ira Driscoll; Sally A Shumaker; Beverly M Snively; Karen L Margolis; JoAnn E Manson; Mara Z Vitolins; Rebecca C Rossom; Mark A Espeland
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-09-27       Impact factor: 6.591

10.  Drug utilization pattern in patients with different types of dementia in Western India.

Authors:  Mansi Patel; Anuradha Joshi; Jalpa Suthar; Soaham Desai
Journal:  Int J Alzheimers Dis       Date:  2014-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.